MAJOR ADVERSE CARDIAC EVENTS
Clinical trials for MAJOR ADVERSE CARDIAC EVENTS explained in plain language.
Never miss a new study
Get alerted when new MAJOR ADVERSE CARDIAC EVENTS trials appear
Sign up with your email to follow new studies for MAJOR ADVERSE CARDIAC EVENTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo aims to shield rheumatoid arthritis patients from heart attacks
Disease control Recruiting nowThis study looks at whether taking tofacitinib (a rheumatoid arthritis drug) along with a statin (a cholesterol-lowering drug) can lower the chance of serious heart problems in people with rheumatoid arthritis. The study will compare this combination to another standard treatment…
Matched conditions: MAJOR ADVERSE CARDIAC EVENTS
Phase: PHASE4 • Sponsor: Shaikh Zayed Hospital, Lahore • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Hospital program aims to tackle heart risk by treating the whole patient
Disease control Recruiting nowThis study is testing whether a planned hospital stay that focuses on managing all of a patient's health problems (like high blood pressure, diabetes, and weight) can lower their risk of a future heart attack or stroke. The study will enroll 70 adults who are already at high risk…
Matched conditions: MAJOR ADVERSE CARDIAC EVENTS
Phase: NA • Sponsor: University Hospital, Montpellier • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC